PDX models play a crucial role in accelerating drug development by providing a more clinically relevant platform for preclinical testing. They enhance the likelihood of success in clinical trials by better predicting how therapies will perform in human patients, ultimately leading to the development of more effective and personalized treatment for cancer.
Growing portfolio of recently collected PDXs to advance personalized medicine approaches
Choose from our growing portfolio of fully characterized PDX models representing multiple histotypes. Our models are recently collected providing a more accurate reflection of human cancer biology compared to older or less relevant models. Plus, we continue to grow our portfolio by adding models consistently.
Cancer types include: